Bharat Biotech acquires licence for GSK’s Shigella vaccine development
Pharmaceutical Technology
JUNE 13, 2025
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Let's personalize your content